Repro 11.2.2 Breast Cancer Flashcards

1
Q

How common is breast cancer?

A

Accounts for 20% of all malignancies in women
1 in 12 women develop breast cancer in their life
1% occurs in men
95% are adenocarcinomas (other malignant tumours of the breast are very rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What increases mens risk of breast cancer?

A

Klinefelter’s syndrome
Male to female transexuals
Men treated with oestrogen for prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where are breast cancers most common?

A

Upper outer quadrant (50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors for development of breast cancer?

A
Gender
Uninterrupted menses
Early menarche (<11)
Late menopause
Obesity and high fat diet
Exogenous oestrogens (HRT, OCP) 
Liver cirrhosis
(All to do with hormones)
Atypical changes on previous biopsy (4-5 times)
Previous breast cancer (x10)
Radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors reduce risk of breast cancer?

A

Reproductive history - parity and age at first full term pregnancy and amount of pregnancies
Breast-feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does geography influence the risk of development of breast cancer?

A

Higher incidence in US and Europe. Possible explanation in diet, physical activity, breast-feeding and environmental factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What % of breast cancers are hereditary?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What genes are most commonly implicated in breast cancer?

A

3% of all breast cancers and 25% of hereditary breast cancers are attributed to mutations in BRCA1 or BRCA2
p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which BRCA gene is also implicated in ovarian cancer?

A

BRCA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are BRCA genes?

A

Tumour supressor genes - their proteins repair damaged DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What % of the population have BRCA germ line mutations?

A

0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the lifetime breast cancer risk for female carriers of BRCA1?

A

60-85%

May undergo prophylactic mastectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When are familial breast cancers usually diagnosed in comparison to sporadic cases?

A

20 years earlier on average

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the classification of breast carcinoma?

A

In situ or invasive

Ductal or lobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are carcinomas in situ?

A

Neoplastic population of cells limited to ducts and lobules by basement membrane, myoepithelial cells are preserved
Does not invade into vessels and therefore cannot metastasise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do most DCIS present?

A

Mammographic calcifications (clusters or linear and branching) but can also present as a mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does DCIS appear microscopically?

A

Often shows central necrosis with calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How might DCIS spread?

A

Can spread through ducts and lobules and be very extensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is DCIS?

A

Ductal carcinoma in situ. Non-obligate precursor of invasive carcinoma

20
Q

How can Paget’s disease present in the breast?

A

Unilateral red crusting nipple

21
Q

What might Paget’s disease of the nipple be mistaken for?

A

Eczematous or inflammatory conditions of the nipple - should be regarded as suspicious and biopsy performed

22
Q

What is the pathophysiology of Paget’s disease in the nipples?

A

Malignant cells can infiltrate epidermis via the mammary duct epithelium. The cells proliferate leading to thickening of the affected skin

23
Q

Define an invasive carcinoma.

A

Invaded beyond BM into stroma. Can invade into vessels and can therefore metastasise to lymph nodes and other sites

24
Q

How does an invasive carcinoma present?

A

Usually as a mass or mammographic abnormality. By the time a cancer is palpable more than half the patients will have axillary lymph node metastases

25
Q

What is peau d’orange?

A

Involvement of lymphatic drainage of the skin gives rise to a dimpled affect by the hair follicles as oedema swells the skin surrounding them. A clinical appearance of breast cancer

26
Q

What are the most common types of invasive carcinoma of the breast?

A

Invasive ductal carcinoma, no special type (IDC NST) (70-80%)
Invasive lobular carcinoma (5-15%)
Tubular, mucinous etc

27
Q

What is the appearance of well/poorly differentiated IDC NST?

A

Well-differentiated - tubules lined by atypical cells

Poorly-differentiated - sheets of pleomorphic cells

28
Q

What is the 10 year survival rate for IDC NST?

A

35-50%

29
Q

What is the microscopic appearance of invasive lobular carcinoma?

A

Infiltrating cells in a single file

Cells lack cohesion

30
Q

What is the prognosis of invasive lobular carcinoma?

A

35-50% 10 year survival rate

31
Q

What are the patterns of metastasis of breast cancer?

A

Lymph nodes via lymphatics (usually ipsilateral axilla)

Distant metastases via blood vessels - bone, lung, liver, brain

32
Q

Where might invasive lobular carcinoma spread?

A
Peritoneum
Retroperitoneum
Leptomeninges
Gastrointenstinal tract
Ovaries
Uterus
33
Q

What factors determine the prognosis of breast cancer?

A
In situ v invasive
Histological subtype - IDC NST has poorer prognosis
Tumour grade
Tumour stage
Gene expression profile
34
Q

What is the basis of tumour staging?

A

Tumour size
Locally advanced disease - invading into skin or skeletal muscle
Lymph node metastases
Distant metastases

35
Q

How is breast cancer investigated and diagnosed?

A

Triple approach:

  1. Clinical - history, fx, examination
  2. Radiographic imaging - mammogram and ultrasound scan
  3. Pathology - fine needle aspiration cytology (FNAC) and core biopsy
36
Q

What is looked for in mammographic screening?

A

Asymmetric desities
Parenchymal deformities
Calcifications

37
Q

How are abnormalities seen in mammographic screening further assessed?

A

Further imaging
FNAC
Core biopsy

38
Q

What are the local treatment options for breast cancer?

A

Breast surgery - mastectomy or breast conserving surgery
Axillary surgery - extent depending on whether there are involved lymph nodes (sentinel node sampling or axillary dissection)
Post-operative radiotherapy to chest and axilla

39
Q

How is the type of breast surgery required determined?

A

Patient choice
Size
Site of tumour
Size of breast

40
Q

What is sentinel lymph node biopsy?

A

Intraoperative lymphatic mapping with dye and/or radioactivity of the draining or ‘sentinel’ lymph node(s) - this is the one most likely to contain breast cancer metastases
If the sentinel node(s) is negative axillary dissection can be avoided

41
Q

What is the systemic therapeutic approach to treatment of breast cancer?

A

Chemo (only if benefits thought to outweigh risks)

Hormonal/herceptin treatment (depending on hormone/Her2 receptor status)

42
Q

What is neoadjuvant chemotherapy?

A

Given before surgery

43
Q

What is Her2?

A

A member of the human epidermal growth factor receptor family
Encodes a transmembrane tryosine kinase receptor

44
Q

What is herceptin?

A

humanised monoclonal antibodies against the Her 2 protein

45
Q

How do oestrogen receptors appear under the microscope?

A

Brown stained nuclei

46
Q

How do Her2 receptors appear under the microscope?

A

Blue stained nuclei, brown cytoplasm

47
Q

How is the survival for breast cancer improved?

A
Early detection
Neoadjuvant chemo
Use of newer therapies
Gene expression profile
Prevention of familial cases